Literature DB >> 20070998

Orbital involvement in Castleman disease.

Ioannis Venizelos1, Thomas G Papathomas, Maria Papathanasiou, Angeliki Cheva, Vasilia Garypidou, Sarah Coupland.   

Abstract

Castleman disease is a quite uncommon lymphoproliferative disorder usually occurring in the lymph nodes. Rarely, Castleman disease develops in an extranodal anatomic location. We report on the first biopsy-proven case of multicentric plasma cell type of Castleman disease involving the orbital areas in a human herpes virus 8 (HHV-8)-unassociated/ human immunodeficiency virus (HIV)-seronegative 70-year-old man suffering from Parkinson disease. The diagnosis was established on the basis of morphologic, immunophenotypic, and molecular findings of a lymph node and orbital soft tissue biopsy. We additionally provide a review of all previously published cases of Castleman disease with an orbital involvement, discussing the distinctive characteristics and potential associations with regard to their counterparts at other sites. Although Castleman disease involving the orbit is an exceptionally rare occurrence that may present initially with ocular signs and symptoms, this should be included in the complete differential diagnosis of orbital mass lesion.

Entities:  

Mesh:

Year:  2010        PMID: 20070998     DOI: 10.1016/j.survophthal.2009.09.003

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  3 in total

1.  Clinical characteristics of a concurrent condition of IgG4-RD and Castleman's disease.

Authors:  Xia Zhang; Panpan Zhang; Linyi Peng; Yunyun Fei; Wei Zhang; Ruie Feng; Wen Zhang
Journal:  Clin Rheumatol       Date:  2018-06-14       Impact factor: 2.980

2.  Relationship between chronic sclerosing dacryoadenitis with high level of IgG4 and Castleman disease.

Authors:  Toshiyuki Oshitari; Jiro Yotsukura; Kaoru Asahagi; Takayuki Baba; Takashi Kishimoto; Shuichi Yamamoto
Journal:  Clin Ophthalmol       Date:  2010-12-30

3.  Refractory uveitis in patient with castleman disease successfully treated with tocilizumab.

Authors:  Toshiyuki Oshitari; Fusae Kajita; Aya Tobe; Makiko Itami; Jiro Yotsukura; Takayuki Baba; Shuichi Yamamoto
Journal:  Case Rep Ophthalmol Med       Date:  2012-11-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.